Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Employee Benefits topic

No spam. Unsubscribe anytime.

Siegel recommends UMR and MetLife after Joplin City insurance RFP; council gets update, no vote

Joplin City Council · June 2, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

At a June 2, 2025 informal Joplin City Council meeting, Siegel presented 2024 plan results and RFP outcomes and recommended awarding medical and prescription drug business to UMR and ancillary lines (dental, vision, life, disability) largely to MetLife and EyeMed, citing projected savings and multi‑year rate guarantees; council asked follow‑up questions but took no formal action.

The Joplin City Council on June 2 received a semiannual insurance update from consultant Siegel that recommended switching several employee benefits contracts after a competitive request‑for‑proposal process and outlined recent plan performance.

Haas, a consultant with Siegel, told the council the city finished 2024 close to budget: “our total expenses were actually less than our revenue by about by $176,468,” and the city’s reserves increased “from $2,900,000 to $3,100,000.” She said first‑quarter 2025 activity produced an operating surplus of about $588,000, driven in part by timing of payroll and prescription‑rebate payments.

Why it matters: the consultant said the RFP process — run once every five years for all lines of coverage — produced options that could lower the city’s overall benefit costs and lock in multi‑year guarantees, potentially reducing budget pressure while changing vendor relationships that affect employee coverage and provider networks.

What Siegel recommended

- Ancillary lines (dental, vision, basic and supplemental life, AD&D, long‑term disability): Siegel recommended awarding dental to MetLife (which proposed benefit enhancements including raising the annual dental maximum and increasing the orthodontia lifetime maximum), vision to EyeMed, and life/disability lines to MetLife where it scored highest on Siegel’s evaluation. The consultant said those changes would yield roughly $33,000 in direct savings on dental in the presentation examples and include rate guarantees of two to four years depending on the product.

- Medical and prescription drugs: of the three medical proposals received (UMR/UnitedHealthcare, Aetna, Anthem), Siegel recommended UMR as the highest scorer overall, citing stronger network discounts, performance guarantees and more favorable rebate assumptions. “We actually expect the UMR proposed contract terms to be superior to the current contract terms by about 10.4%,” Haas said. UMR and Aetna offered five‑year administrative fee guarantees on some elements; Anthem proposed a three‑year guarantee for admin fees.

Plan performance and claims context

Haas reviewed trends that informed the RFP analysis: large claim activity is variable (a claimant near $700,000 in 2022), and Siegel reported 23 members with claims above $50,000 in 2024 compared with 14 in 2023 (the consultant noted specialty prescription drugs are driving growth in high‑cost members). She also highlighted prescription drug rebates as a meaningful offset — roughly 30% of paid prescription claims in the consultant’s presentation — and said about $210,000 in prescription rebates hit in January, affecting quarter‑to‑quarter comparisons.

Other issues and staff follow‑up

Councilmember Jackson praised the results and asked whether voluntary products (critical‑illness or accident insurance) could be offered so employees and families would have additional protection without cost to the city; Siegel said voluntary benefits and implementation credits could be explored and that payroll integration would simplify enrollment. The consultant also recommended surveying employees on interest in HSA‑qualified plans and continuing to evaluate coverage for GLP‑1 weight‑loss drugs, which currently cost more than $1,000 per month and lack long‑term outcome data; she noted a pending federal executive order could change pricing dynamics significantly if implemented.

No formal action taken

The presentation concluded with Siegel’s recommendations and appendices with carrier financial ratings and detailed scoring. Council thanked the presenters; the informal session ended at 5:57 p.m. and council recessed for a short break. Council did not take a formal vote on the RFP awards during this session; next steps described were internal — finalizing BAFO results and staff work to complete contract language and implementation planning.

Clarifying details reported by Siegel: 2024 ended about $176,468 in surplus; reserves rose from $2,900,000 to $3,100,000; Q1 2025 contributions were about $2,200,000 with $1,600,000 in expenses (operating surplus ~$588,000); Siegel presented a dental savings example of roughly $33,000; Siegel cited 23 members with claims over $50,000 in 2024 and referenced a near‑$700,000 claimant in 2022; Siegel estimated UMR terms would be ~10.4% better than current terms when modeled to 2026. Where the transcript contained an apparent transcription error (it reads “14,000” for 2023 large claimants), the consultant’s context and typical reporting indicate the intended comparison was 14 members in 2023 rather than 14,000 members.

What’s next: staff will use Siegel’s RFP scoring and BAFO analysis to proceed with vendor selection and contract negotiations; council raised implementation questions (payroll hookup for voluntary lines, employee interest in HSA) that staff said they would explore before contracts are finalized.